Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-26 Disposition | 2024-08-26 5:42 pm | N/A N/A | AGILE THERAPEUTICS INC | AGRX | Coiante Scott M Chief Financial Officer | 20,080 | $1.52 | 0 (Direct) | View |
| 2023-10-03 Option Award | 2023-10-04 4:45 pm | N/A N/A | AGILE THERAPEUTICS INC | AGRX | Coiante Scott M Chief Financial Officer | 20,000 | $0 | 20,080 (Direct) | View |
Ownership | 2023-08-25 4:02 pm | N/A N/A | AGILE THERAPEUTICS INC | AGRX | Coiante Scott M Chief Financial Officer | 0 | $0 | 80 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:00 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 150,000 | $0 | 234,265 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:02 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 35,284 | $0.805 | 84,265 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:02 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 228,800 | $0 | 305,449 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 14,817 | $1.74 | 76,649 (Direct) | View |
| 2021-08-25 Tax Withholding | 2021-08-27 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 7,534 | $3.98 | 91,466 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 7:03 pm | N/A 2031-02-25 | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 239,500 | $0 | 242,000 (Direct) | View |
| 2020-03-24 Option Award | 2020-03-26 5:00 pm | N/A 2030-03-24 | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 55,000 | $0 | 55,000 (Direct) | View |